Publications & Posters

VIEW:

All
Publications
Posters

The below publications outline research from Qlaris Bio's initial formulation, QLS-101. Based on this research, we have now developed a new formulation of our program, called QLS-111.

Journal of Ocular Pharmacology and Therapeutics

Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent

June 12, 2023

Read Publication

Investigative Ophthalmology & Visual Science

Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug

May 5, 2022

Read Publication

Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents

October 10, 2017

Read Publication